PVA SLS Dosage Forms for Stable Amorphous API Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing selective laser sintering (SLS) methods using polyvinyl alcohol (PVA) as a pharmaceutical excipient face challenges in achieving stable amorphous forms of poorly soluble active pharmaceutical ingredients (APIs) due to unpredictable melting and coalescence behaviors, leading to reduced bioavailability and rapid recrystallization.
Innovation Solution
The use of PVA with a hydrolysis degree of 70% to 90% and viscosity of 3 to 8 mPas in a 4% solution at 20°C for selective laser sintering, forming a pharmaceutical dosage form that stabilizes amorphous APIs, ensuring long-term stability and improved release characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polyvinyl alcohol is used as excipient in SLS to improve solubility of poorly soluble APIs, then bioavailability is improved, but recrystallization occurs rapidly reducing bioavailability
Solution Approach 1:
The patent applies parameter changes by selecting specific PVA grades with controlled hydrolysis degree (70-90%) and viscosity (3-8 mPas) to optimize the balance between solubility enhancement and stability. This systematic parameter optimization prevents recrystallization while maintaining bioavailability improvements.
Solution Approach 2:
The patent creates composite amorphous solid dispersions combining APIs with specifically selected PVA grades. This composite approach stabilizes the amorphous form through the synergistic interaction between the API and the optimized PVA matrix, preventing recrystallization while maintaining enhanced solubility and bioavailability.
2Productivity
If PVA is used to form amorphous solid dispersions to increase solubility, then API release is enhanced, but the amorphous form is unstable and re-crystallizes
Solution Approach 1:
The patent optimizes PVA parameters (hydrolysis degree and viscosity) to achieve the desired balance between rapid API release and amorphous form stability. The specific parameter range prevents recrystallization during the dissolution process, maintaining both high release rate and form stability.
Solution Approach 2:
The patent utilizes the temporary amorphous state of the API-PVA dispersion that rapidly dissolves and releases the API. The amorphous form serves its purpose of enhancing solubility and release rate, then naturally transitions to dissolved state, avoiding the need for long-term stability preservation.
3Ease of manufacture
If conventional PVA grades are used in SLS, then manufacturing is simplified, but unpredictable melting and coalescence behaviors occur
Solution Approach 1:
The patent establishes specific PVA parameter ranges (hydrolysis degree 70-90%, viscosity 3-8 mPas) that provide both ease of manufacture and predictable melting/coalescence behavior. These parameter specifications ensure reliable SLS processing while maintaining manufacturing simplicity.
Solution Approach 2:
The patent replaces trial-and-error material selection with a systematic parameter-based approach. By substituting empirical testing with defined parameter specifications, the process achieves both simplicity and predictability in melting and coalescence behavior.
4Reliability
If PVA is used to stabilize amorphous APIs, then bioavailability is improved, but the process requires specific PVA grades with controlled properties
Solution Approach 1:
The patent defines specific parameter ranges for PVA (hydrolysis degree 70-90%, viscosity 3-8 mPas) that balance bioavailability enhancement with manageable specification requirements. These parameter specifications provide clear guidance for material selection without excessive complexity.
Solution Approach 2:
The patent identifies PVA grades within the specified ranges that serve multiple functions: stabilizing amorphous forms, enhancing solubility, improving bioavailability, and enabling reliable SLS processing. This multi-functionality reduces the need for multiple specialized materials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The specified PVA grades facilitate faster API release, enhanced amorphization, and improved bioavailability by preventing crystallization, maintaining API stability in aqueous media for over 6 months, and enhancing supersaturation.
Implementation Method 1
The process applies layers of powder material on top of each other sequentially, where each layer of powder is sintered or coalesced together with a laser
Implementation Method 2
each layer of powder is sintered or coalesced together with a laser according to the computer aided drawing (CAD) geometry of the part
Implementation Method 3
enhancing supersaturation
Implementation Method 4
preventing crystallization, maintaining API stability in aqueous media for over 6 months
Implementation Method 5
enhanced amorphization
Implementation Method 6
improved solubility of poorly soluble active pharmaceutical ingredients
Data Source
AI summary
The present disclosure generally relates to the use of polyvinyl alcohol (PVA) in additive manufacturing technologies and techniques. More specifically, the present disclosure relates to the use of PVA in a selective laser sintering (SLS) method to additively manufacture an object, in particular a pharmaceutical dosage form.